🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Varex Imaging Corporation VREX R2K

Healthcare · Medical Devices · United States
https://www.vareximaging.com

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

READ MORE ›
$10.23
+33.38% 1Y

Market & Price

Market Cap
$431.16M
Current Price
$10.23
High / Low (52W)
$14.36 / $6.96
Beta
0.96

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
9.58
PEG Ratio
4.98
Book Value
$11.38
Price to Book
0.90
P/S
0.50
EV/EBITDA
8.22
Dividend Yield
-

Profitability & Returns

ROCE
-2.88%
ROE
-15.68%
ROA
3.20%
Profit Margin
-9.64%
Op Margin
6.67%
EPS (Latest Qtr)
$-0.19
EPS (TTM)
$-2.00

Balance Sheet & Liquidity

Debt/Equity
0.78
Quick Ratio
1.21
Current Ratio
3.20
Debt
$381.00M
Total Assets
$1.11B
Current Assets
$641.80M
Working Capital
$454.60M

Ownership

Promoter Holding
1.63%
Chg in Prom Hold
-
FII / Inst Holding
101.29%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$737.28M
Total Revenue (TTM)
$857.50M
EBITDA
$89.70M
Free Cash Flow
$-40.27M
Operating Cash Flow
$-2.00M
Shares Outstanding
42.15M
Gross Margin
33.55%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
-0.58%
Profit 5Y
-110.67%
Revenue (YoY)
1.50%
Earnings (YoY)
-

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -0.6% CAGR over 5 years.
  • Earnings shrank at -110.7% CAGR over 5 years.
  • Trading 28.8% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 VREX Varex Imaging Corporation R2K 10.23 - $431.16M - -2.88% -15.68% -0.58% -110.67%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Jan 2016Apr 2016Jul 2016Dec 2016Mar 2017Jun 2017Dec 2017Mar 2018Jun 2018Dec 2018Mar 2019Jun 2019Jan 2020Apr 2020Jul 2020Jan 2021Apr 2021Jul 2021Dec 2021Apr 2022Jul 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Jan 2025Mar 2025Apr 2025Jun 2025Jul 2025Sep 2025Dec 2025Jan 2026Mar 2026Apr 2026
Revenue ------176.20M201.20M191.20M185.70M195.80M196.70M200.10M197.00M171.20M177.10M203.50M211.20M198.80M214.70M214.50M205.60M228.20M232.20M190.00M206.20M209.10M199.80M212.90M212.90M203.00M203.00M228.90M209.60M209.60M216.00M216.00M
Cost of Revenue ----------------------------136.20M-135.50M-151.10M139.80M-143.40M-
Gross Profit 57.10M59.10M63.00M58.80M57.60M59.50M61.50M70.10M63.00M60.00M64.40M60.70M61.10M57.60M26.30M57.20M64.60M74.10M64.80M70.80M73.40M63.30M72.70M76.30M57.10M65.80M66.90M68.50M76.70M76.70M67.50M67.50M77.80M69.80M69.80M72.60M72.60M
Operating Expenses ----------------------------54.60M-54.30M-58.20M54.40M-58.20M-
Operating Income 22.60M25.20M28.40M18.60M23.50M15.50M13.60M17.20M7.30M10.40M14.50M4.60M4.60M1.40M-26.80M6.10M15.80M25.70M14.00M26.60M23.00M13.00M15.60M24.20M4.20M7.70M9.30M11.20M22.10M22.10M13.20M-80.70M19.60M15.40M15.40M14.40M14.40M
EBITDA ----------------------------26.80M--71.10M-28.30M18.00M-7.90M-
Interest Expense ----------------------------9.40M-8.70M-7.50M7.40M-7.50M-
Pretax Income ----------------------------10.80M--86.60M-14.10M3.80M--6.40M-
Tax Provision ----------------------------3.70M-2.50M-1.90M1.40M-1.60M-
Net Income 14.10M14.70M17.60M11.10M15.00M10.60M11.30M12.20M3.80M3.00M5.80M-1.40M-1.30M-1.90M-28.30M-6.40M3.10M12.00M1.40M7.60M8.20M3.10M4.10M9.10M-500.00K1.40M1.40M-300.00K6.90M6.90M-89.10M-89.10M12.20M2.30M2.30M-8.10M-8.10M
Diluted EPS -0.390.470.290.400.280.300.320.100.080.15-0.04-0.03-0.05-0.73-0.160.080.290.030.180.200.080.100.21-0.010.030.03-0.010.170.17-2.15-2.150.290.050.05-0.19-0.19
R&D Expense 12.50M13.10M14.00M13.30M14.40M17.70M19.70M22.00M20.50M18.80M18.80M20.90M21.70M20.90M19.00M16.70M18.20M19.20M17.70M18.90M20.20M20.00M23.00M20.00M20.50M22.60M22.00M23.50M-22.00M-21.40M--21.70M-22.20M

Profit & Loss (Annual)

Figures in USD.

Metric Oct 2015Sep 2016Sep 2017Sep 2018Sep 2019Oct 2020Oct 2021Sep 2022Sep 2023Sep 2024Sep 2025Oct 2025
Revenue ------818.10M859.40M893.40M811.00M844.60M844.60M
Cost of Revenue -------575.90M603.10M554.10M554.10M-
Gross Profit 250.60M248.40M253.50M253.90M256.70M190.20M271.50M283.50M290.30M256.90M290.50M290.50M
Operating Expenses -------195.30M213.20M224.80M224.40M-
Operating Income 127.50M109.10M83.70M44.50M45.70M-33.70M74.10M88.20M77.10M32.10M66.10M-27.80M
EBITDA -------114.50M91.20M62.90M700.00K-
Interest Expense -------36.40M26.70M26.80M32.70M-
Pretax Income -------44.50M31.30M5.00M-59.20M-
Tax Provision -------13.70M-16.60M53.30M10.70M-
Net Income 80.00M68.50M51.60M27.50M15.50M-57.90M17.40M30.30M47.40M-48.80M-70.30M-70.30M
Diluted EPS 2.121.821.360.720.40-1.490.430.731.08-1.17-1.70-1.70
R&D Expense 50.40M53.50M67.30M83.00M78.10M78.90M71.90M77.00M84.80M87.00M-91.10M

Compounded Sales Growth

5 Years:-0.58%
1 Year:1.50%

Compounded Profit Growth

5 Years:-110.67%
1 Year:-

Stock Price Performance

1 Year:+33.38%
6 Months:-8.74%
3 Months:-22.32%
1 Month:-7.25%

Balance Sheet (Annual)

Figures in USD.

Metric Sep 2014Oct 2015Sep 2016Sep 2017Sep 2018Sep 2019Oct 2020Sep 2021Oct 2021Sep 2022Sep 2023Sep 2024Sep 2025Oct 2025
Total Assets --622.40M1.04B987.90M1.04B1.14B-1.15B1.18B1.25B1.21B1.11B1.11B
Current Assets ---------609.90M658.30M649.90M641.80M-
Cash & Equivalents 500.00K20.60M36.50M83.30M51.90M29.90M100.60M-144.60M89.40M152.60M168.70M145.00M145.00M
Inventory ---------303.20M277.50M264.80M299.40M-
Receivables ---------173.30M163.60M157.70M156.60M-
Total Liabilities --86.10M649.90M548.50M580.20M673.70M-651.00M637.70M668.60M670.40M620.80M620.80M
Current Liabilities --77.80M151.80M152.00M175.10M160.60M-166.60M173.10M162.80M195.90M187.20M187.20M
Long Term Debt --0463.90M364.80M364.40M452.80M-431.70M412.30M441.10M397.10M366.00M366.00M
Total Debt ---------436.40M469.50M470.40M395.90M-
Total Equity --526.00M379.00M426.20M444.90M451.70M-483.30M533.40M567.70M529.10M472.60M472.60M
Shares Outstanding ---------40.09M40.53M41.09M41.69M-

Cash Flows (Annual)

Figures in USD.

Metric Oct 2015Sep 2016Sep 2017Sep 2018Sep 2019Oct 2020Sep 2021Oct 2021Sep 2022Sep 2023Sep 2024Sep 2025Oct 2025
Operating Cash Flow 85.20M74.20M75.20M85.30M71.90M13.20M-92.60M16.90M108.40M47.30M41.70M41.70M
Investing Cash Flow -102.10M-21.60M-292.00M-25.20M-93.20M-26.90M--16.20M-48.40M-44.90M-27.50M10.30M10.30M
Financing Cash Flow 36.70M-36.80M263.30M-90.40M-100.00K83.60M--32.30M-23.80M-200.00K-3.30M-75.90M-75.90M
Capital Expenditure -34.30M-28.90M-20.20M-20.40M-19.80M-23.50M--15.10M-21.30M-20.70M-26.90M-22.90M-22.90M
Free Cash Flow 50.90M45.30M55.00M64.90M52.10M-10.30M-77.50M-4.40M87.70M20.40M18.80M18.80M
Net Change in Cash ---------55.30M63.30M16.50M-23.90M-

Ratios (Annual)

Figures in %.

Metric Oct 2015Sep 2016Sep 2017Sep 2018Sep 2019Oct 2020Oct 2021Sep 2022Sep 2023Sep 2024Sep 2025Oct 2025
Gross Margin % ------33.2%33.0%32.5%31.7%34.4%34.4%
Operating Margin % ------9.1%10.3%8.6%4.0%7.8%-3.3%
Net Margin % ------2.1%3.5%5.3%-6.0%-8.3%-8.3%
ROE % -13.0%13.6%6.5%3.5%-12.8%3.6%5.7%8.3%-9.2%-14.9%-14.9%
ROCE % -20.0%9.4%5.3%5.3%-3.4%7.6%8.7%7.1%3.2%7.2%-3.0%

Shareholding Pattern

Insiders
1.63%
Institutions
101.29%
Public Float
102.97%

Top Institutional Holders

#Holder% HeldSharesValue
1 Pzena Investment Management LLC 9.48% 3.99M $40.84M
2 Blackrock Inc. 9.07% 3.82M $39.06M
3 Allspring Global Investments Holdings, LLC 6.29% 2.65M $27.08M
4 Neuberger Berman Group, LLC 4.57% 1.92M $19.69M
5 Vanguard Capital Management LLC 4.32% 1.82M $18.62M
6 LSV Asset Management 4.19% 1.76M $18.03M
7 Dimensional Fund Advisors LP 3.70% 1.56M $15.94M
8 Cooke & Bieler LP 3.10% 1.30M $13.33M
9 Rice, Hall, James & Associates LLC 3.03% 1.27M $13.04M
10 Medina Value Partners, LLC 2.95% 1.24M $12.70M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for VREX

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks